Dr David Brindley

Dr David Brindley is an independent Non-Executive Director of Arkivum limited, bringing significant experience in GxP regulated life science applications. David leads the Healthcare Translation Group at the University of Oxford and is COO of a US vaccine company. Previously, David conducted research at the University of Oxford, University College London (UCL), Stanford University and Harvard University. Under David’s leadership a number of therapeutics and medical devices have entered clinical trials and achieved marketing authorization in the EU and US.